Representative Julia Letlow (Republican-Louisiana) recently sold shares of Icon Plc (NASDAQ:ICLR). In a filing disclosed on March 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Icon stock on February 12th. The trade occurred in the Representative’s “MERRILL LYNCH INVESTMENT ACCOUNT #025” account.
Representative Julia Letlow also recently made the following trade(s):
- Sold $1,001 – $15,000 in shares of HF Sinclair (NYSE:DINO) on 2/20/2026.
- Sold $1,001 – $15,000 in shares of BXP (NYSE:BXP) on 2/20/2026.
- Purchased $1,001 – $15,000 in shares of Travelers Companies (NYSE:TRV) on 2/20/2026.
- Sold $1,001 – $15,000 in shares of Expand Energy (NASDAQ:EXE) on 2/17/2026.
- Sold $1,001 – $15,000 in shares of Public Service Enterprise Group (NYSE:PEG) on 2/17/2026.
- Purchased $1,001 – $15,000 in shares of Vistra (NYSE:VST) on 2/17/2026.
- Purchased $1,001 – $15,000 in shares of Regeneron Pharmaceuticals (NASDAQ:REGN) on 2/12/2026.
- Purchased $1,001 – $15,000 in shares of Extra Space Storage (NYSE:EXR) on 2/12/2026.
- Sold $1,001 – $15,000 in shares of AT&T (NYSE:T) on 2/12/2026.
- Sold $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 2/12/2026.
Icon Stock Up 0.7%
ICLR opened at $100.35 on Tuesday. Icon Plc has a 12 month low of $66.57 and a 12 month high of $211.00. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.31. The business’s 50-day moving average price is $132.92 and its 200-day moving average price is $162.07. The company has a market cap of $8.10 billion, a P/E ratio of 13.58, a P/E/G ratio of 2.55 and a beta of 1.35.
Hedge Funds Weigh In On Icon
Analyst Ratings Changes
ICLR has been the subject of several recent research reports. BMO Capital Markets reiterated a “market perform” rating and issued a $100.00 price objective on shares of Icon in a research report on Thursday, February 12th. Bank of America reaffirmed an “underperform” rating and issued a $75.00 target price on shares of Icon in a research note on Thursday, February 12th. Robert W. Baird set a $119.00 price target on shares of Icon in a report on Friday, February 13th. Zacks Research lowered shares of Icon from a “hold” rating to a “strong sell” rating in a report on Wednesday, February 25th. Finally, Citigroup decreased their price objective on shares of Icon from $200.00 to $120.00 and set a “neutral” rating on the stock in a research report on Wednesday, March 11th. Six research analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $146.80.
View Our Latest Analysis on ICLR
About Representative Letlow
Julia Letlow (Republican Party) is a member of the U.S. House, representing Louisiana’s 5th Congressional District. She assumed office on April 14, 2021. Her current term ends on January 3, 2027.
Letlow (Republican Party) is running for re-election to the U.S. House to represent Louisiana’s 5th Congressional District. She declared candidacy for the primary scheduled on November 3, 2026.
Julia Letlow earned a doctorate. Letlow’s career experience includes working as a senior administrator with the University of Louisiana at Monroe.
Icon Company Profile
Icon plc (NASDAQ: ICLR) is a global provider of outsourced drug development and clinical research services to the pharmaceutical, biotechnology and medical device industries. The company partners with clients at all stages of the product life cycle, offering expertise in protocol design, trial execution and regulatory compliance across a broad range of therapeutic areas.
Icon’s service portfolio encompasses clinical trial management, data management and biostatistics, medical imaging, pharmacovigilance and safety monitoring, laboratory sciences and specialized analytical solutions.
See Also
Receive News & Ratings for Icon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon and related companies with MarketBeat.com's FREE daily email newsletter.
